Skip to main navigation

Who We Are
- Leadership Team
- Board of Directors
Our Platform
- Publications
Our Pipeline
- Inflammatory Diseases
Patients, Families & Physicians
Investors & Media

Careers
Contact Us

Evelo

Investor Relations
News & Events
SEC Filings
Stock
Analyst Coverage
Governance

News & Events

News Releases

Year

Evelo Biosciences to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021

October 21, 2021

Evelo Biosciences Presents Preclinical Data for EDP1867 at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

October 13, 2021

Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis; Confirms Ability to Harness the Small Intestinal Axis, SINTAX™, to Treat Systemic Inflammatory Disease

September 27, 2021

Evelo Biosciences to Present at 2021 Cantor Global Healthcare Conference

September 20, 2021

Evelo Biosciences Announces Issuance of U.S. Patent for Pharmaceutical Compositions of Single Strains of Naturally Occurring Bacteria as Medicines

September 9, 2021

Evelo Biosciences Appoints Iain McInnes, M.B.Ch.B, Ph.D, to Board of Directors

September 7, 2021

Evelo Biosciences Reports Second Quarter 2021 Financial Results and Business Highlights

July 29, 2021

Evelo Biosciences to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021

July 22, 2021

Evelo Biosciences Announces Grant of Inducement Award

July 14, 2021

Evelo Biosciences Announces Grant of Inducement Award

June 16, 2021

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Upcoming Events

Third Quarter 2021 Financial Results and Recent Business Highlights

Oct 28, 2021 at 8:30 AM EDT

Listen to webcast

Add to Google Calendar

Past Events

JMP Securities 2018 Life Sciences Conference

Jun 21, 2018 at 8:00 AM EDT

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

Email Alerts

Investor Contact

Investor Contact

Investor FAQs

RSS Feeds

© Evelo Biosciences, Inc.